A. . Sathyan, “A Comprehensive Review of Evidence and Challenges in Switching from Originator Drugs to Biosimilars of Monoclonal Antibodies: Focus on Rituximab and Trastuzumab”, J. Drug Delivery Ther., vol. 15, no. 2, pp. 149–155, Feb. 2025, doi: 10.22270/jddt.v15i2.7012.